has been cited by the following article(s):
[1]
|
Hyperforin: A natural lead compound with multiple pharmacological activities
|
|
Phytochemistry,
2022 |
|
|
[2]
|
Targeting autophagy and neuroinflammation pathways with plant‐derived natural compounds as potential antidepressant agents
|
|
Phytotherapy Research,
2022 |
|
|
[3]
|
Phytochemical screening and antimicrobial activity of various marine microalgae and cyanobacteria
|
|
Hydrobiological Journal,
2022 |
|
|
[4]
|
COVID-19 Pandemic, Part II: What to Do and Who Is to Blame? Viruses as Part of a Necessary Ecosystem, Possible Prophylactic Medication, Immunity
|
|
Voice of the Publisher,
2021 |
|
|
[5]
|
COVID-19 Pandemic, Part I: What to Do and Who to Blame? Susceptibility to Viral Infection via Jeopardized Immunity
|
|
2020 |
|
|
[6]
|
Why Judaism and Islam Prohibit Eating Pork and Consuming Blood as a Food?
|
|
2018 |
|
|
[7]
|
One-Step Procedure for Direct Purification of Pediocin-Like Bacteriocins and Cationic Antimicrobial Peptides from Complex Culture Medium on an Analytical …
|
|
2018 |
|
|
[8]
|
Super Antibiotics: Part V. Doxycycline
|
|
2017 |
|
|
[9]
|
Super Antibiotics: Part III. Hyperforin, Revision of the Relative and Absolute Stereochemistry Presented by Bystrov et al.
|
|
2017 |
|
|
[10]
|
Super Antibiotics, Part I. Hyperforin
|
|
2016 |
|
|
[1]
|
Hyperforin modulates MAPK/CCL11 signaling to reduce the inflammatory response of nasal mucosal epithelial cells caused by allergic rhinitis by targeting BCL6
Experimental and Therapeutic Medicine,
2023
DOI:10.3892/etm.2023.12278
|
|
|
[2]
|
Targeting autophagy and neuroinflammation pathways with plant‐derived natural compounds as potential antidepressant agents
Phytotherapy Research,
2022
DOI:10.1002/ptr.7551
|
|
|
[3]
|
Super Antibiotics: Part V. Doxycycline
Voice of the Publisher,
2017
DOI:10.4236/vp.2017.34006
|
|
|
[4]
|
Super Antibiotics: Part III. Hyperforin, Revision of the Relative and Absolute Stereochemistry Presented by Bystrov et al.
Voice of the Publisher,
2017
DOI:10.4236/vp.2017.32002
|
|
|
[5]
|
Super Antibiotics, Part I. Hyperforin
Voice of the Publisher,
2016
DOI:10.4236/vp.2016.24004
|
|
|